Metformin reverses fatty liver disease in obese, leptin-deficient mice
Metformin reverses fatty liver disease in obese, leptin-deficient mice
About this item
Full title
Author / Creator
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
There is no known treatment for fatty liver, a ubiquitous cause of chronic liver disease. However, because it is associated with hyperinsulinemia and insulin-resistance, insulin-sensitizing agents might be beneficial. To evaluate this possibility, insulin-resistant ob/ob mice with fatty livers were treated with metformin, an agent that improves hep...
Alternative Titles
Full title
Metformin reverses fatty liver disease in obese, leptin-deficient mice
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_72243203
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_72243203
Other Identifiers
ISSN
1078-8956
E-ISSN
1546-170X
DOI
10.1038/79697
